Open interest in Tesla (TSLA) contracts on the Bitget exchange increased significantly over a 24-hour period as of October 16. This rise indicates that more investors are holding open positions in Tesla contracts, reflecting growing interest or confidence in the stock's future movement. Open interest measures the total value of these active positions, providing insight into market sentiment and potential trading volume. This trend may signal increased trading activity or speculation around Tesla shares on the Bitget platform.
The Bitget Tesla contract open interest rise provides context for readers interested in market activity. For readers following major cryptocurrencies on Pluang as of Oct 17, 2026 00:22 WIB, breadth showed 16 of 50 assets rising and 33 falling. Among notable movers, CAKE dropped 4.41% to Rp38.237 with a typical hold time of 75 days and a balanced Pluang order activity of 49% Sell / 51% Buy, contrasting with DOT which gained 3.79% to Rp20.559 and saw a strong buy bias at 96% with a longer hold time of 121 days.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
